1-4 of 4
M. Dugan
Close
Sort by
Journal Articles

LBH589, a Novel Deacetylase Inhibitor (DACi), Treatment of Patients with Cutaneous T-Cell Lymphoma (CTCL). Skin Gene Expression Profiles in the First 24 Hours Related to Clinical Response Following Therapy.

Miles Prince, MBBS, D.J. George, MD, R. Johnstone, PhD, C. McCormack, MBBS, L. Ellis, PhD, R. Williams-Truax, P. Atadja, PhD, C. Zhao, MD, M. Dugan, MD, K. Culver, MD
Journal: Blood
Blood (2006) 108 (11): 2715.
https://doi.org/10.1182/blood.V108.11.2715.2715
Published: 2006
Journal Articles

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).

Hagop M. Kantarjian, MD, O. Ottman, MD, Jorge Cortes, MD, M. Wassman, MD, L. Wunderle, MD, K. Bhalla, MD, D. Jones, MD, A. Hochhaus, MD, P. Rae, L. Alland, MD, M. Dugan, MD, M. Albitar, MD, Francis Giles, MD
Journal: Blood
Blood (2005) 106 (11): 37.
https://doi.org/10.1182/blood.V106.11.37.37
Published: 2005
Journal Articles

Phosphorylation Levels of BCR-ABL, Stat5, and CrkL Proteins in Imatinib-Resistant CML Patients as Compared to Previously Untreated CML Patients: Implication of Poor Drug Binding and Activation of Alternate Pathways.

M. Gorre, H. Kantarjian, I. Jilani, J. Cortes, A. Salvado, P. Rae, L. Alland, M. Dugan, O. Ottmann, K. Bhalla, F. Giles, M. Albitar
Journal: Blood
Blood (2005) 106 (11): 2001.
https://doi.org/10.1182/blood.V106.11.2001.2001
Published: 2005
Journal Articles

A Phase I/II Study of AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, on a Continuous Daily Dosing Schedule in Adult Patients (pts) with Imatinib-Resistant Advanced Phase Chronic Myeloid Leukemia (CML) or Relapsed/Refractory Philadelphia Chromosome (Ph+) Acute Llymphocytic Leukemia (ALL).

Francis Giles, MD, H. Kantarjian, MD, B. Wassmann, J. Cortes, MD, S. O’Brien, MD, C. Tanaka, P. Rae, W. Mietlowski, A. Romano, L. Alland, M. Dugan, M. Albitar, MD, O. Ottmann
Journal: Blood
Blood (2004) 104 (11): 22.
https://doi.org/10.1182/blood.V104.11.22.22
Published: 2004